文献
J-GLOBAL ID:202002263143007668
整理番号:20A1556388
ファビピラビル: 2019-nCoV感染の臨床試験に関する薬物動態と懸念【JST・京大機械翻訳】
Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019-nCoV Infection
著者 (6件):
Du Yin-Xiao
(Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, China)
,
Du Yin-Xiao
(Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, Hunan, China)
,
Du Yin-Xiao
(National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China)
,
Chen Xiao-Ping
(Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, China)
,
Chen Xiao-Ping
(Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, Hunan, China)
,
Chen Xiao-Ping
(National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China)
資料名:
Clinical Pharmacology & Therapeutics
(Clinical Pharmacology & Therapeutics)
巻:
108
号:
2
ページ:
242-247
発行年:
2020年
JST資料番号:
A0721B
ISSN:
0009-9236
資料種別:
逐次刊行物 (A)
記事区分:
文献レビュー
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)